RECRUITING

GYNEMESH PS Mesh Post Marketing Clinical Follow-Up Study

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The objective of this retrospective and prospective, single-arm, observational, multicenter, post-market study is to evaluate outcomes in women who underwent surgery for vaginal or uterine prolapse with a GYNEMESH PS Mesh.

Official Title

A Retrospective and Long-Term Prospective Post Market Clinical Follow-up (PMCF) Study of the GYNECARE GYNEMESH® PS Nonabsorbable PROLENE® Soft Mesh

Quick Facts

Study Start:2021-11-24
Study Completion:2032-03-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04829058

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:21 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Female subjects who had laparotomic or laparoscopic abdominal sacrocolpopexy, including robotic-assisted, for apical vaginal or uterine prolapse
  2. 2. GYNEMESH PS Mesh was used as a bridging material according to the IFU.
  3. 3. Able and willing to participate in follow-up
  4. 4. Subject or authorized representative has signed the approved informed consent
  5. 1. Subjects \< 21 years of age at the time of informed consent
  6. 2. Subjects who had transvaginal approach for surgery
  7. 3. Had undergone a uterus-sparing procedure (sacrohystero or sacrocervicopexy)
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Christine Romanowski
CONTACT
908-808-6219
cromanow@its.jnj.com

Principal Investigator

Martin Weisberg, MD
STUDY_DIRECTOR
Ethicon, Inc.

Study Locations (Sites)

Institute for Female Pelvic Medicine
North Wales, Pennsylvania, 19454
United States
UMPC
Pittsburgh, Pennsylvania, 15213
United States

Collaborators and Investigators

Sponsor: Ethicon, Inc.

  • Martin Weisberg, MD, STUDY_DIRECTOR, Ethicon, Inc.

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-11-24
Study Completion Date2032-03-31

Study Record Updates

Study Start Date2021-11-24
Study Completion Date2032-03-31

Terms related to this study

Keywords Provided by Researchers

  • GYNECARE GYNEMESH® PS Nonabsorbable PROLENE® Soft Mesh
  • POP

Additional Relevant MeSH Terms

  • Pelvic Organ Prolapse